Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population

Archives of Gerontology and Geriatrics

Volumn 53, Issue 3, 2011, Pages 354-358

  Kayaalti, Zeliha ^a   Şahiner, Levent ^b   Durakoĝlugil, M Emre ^b   Söylemezoĝlu, Tülin ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gene polymorphism; Interleukin 6 (IL 6); Longevity; Metallothionein 2A; Polymerase chain reaction restriction fragment length polymorphism (PCR RFLP)

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; ETHNIC GROUP; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; GROUPS BY AGE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; INTERLEUKIN 6 GENE; LONGEVITY; MALE; METALLOTHIONEIN 2A GENE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TURKISH;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; ALLELES; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; LONGEVITY; MALE; METALLOTHIONEIN; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; TURKEY; YOUNG ADULT;

EID: 80051671850     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2011.01.001     Document Type: Article

References (42)

1. Albani D., Batelli S., Polito L., Prato F., Pesaresi M., Gajo G.B., De Angeli S., Zanardo A., Galimberti D., Scarpini E., Gallucci M., Forloni G. Interleukin-6 plasma level increases with age in an Italian elderly population (" The Treviso Longeva" -Trelong-study) with a sex-specific contribution of rs1800795 polymorphism. Age (Dordr) 2009, 31:155-162.
2. Berghe V.W., Vermeulen L., De Wilde G., De Bosscher K., Boone E., Haegeman G. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol. 2000, 60:1185-1195.
3. Bonafè M., Olivieri F., Cavallone L., Giovagnetti S., Mayegiani F., Cardelli M., Pieri C., Marra M., Antonicelli R., Lisa R., Rizzo M.R., Paolisso G., Monti D., Franceschi C. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol. 2001, 31:2357-2361.
4. Capurso C., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso S.A., Semeraro C., Capurso A., Panza F. Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles. Exp. Gerontol. 2004, 39:1109-1114.
5. Caruso C., Lio D., Cavallone L., Franceschi C. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 2004, 1028:1-13.
6. Christiansen L., Bathum L., Andersen-Ranberg K., Jeune B., Christensen K. Modest implication of interleukin-6 promoter polymorphisms in longevity. Mech. Ageing Dev. 2004, 125:391-395.
7. Cipriano C., Malavolta M., Costarelli L., Giacconi R., Muti E., Gasparini N., Cardelli M., Monti D., Mariani E., Mocchegiani E. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 2006, 7:357-365.
8. Cousins R.J., Leinart A.S. Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin 1. FASEB J. 1988, 2:2884-2890.
9. Davis S.R., Cousins R.J. Metallothionein expression in animals: a physiological perspective on function. J. Nutr. 2000, 130:1085-1088.
10. Di Bona D., Vasto S., Capurso C., Christiansen L., Deiana L., Franceschi C., Hurme M., Mocchegiani E., Rea M., Lio D., Candore G., Caruso C. Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res. Rev. 2009, 8:36-42.
11. Ebadi M., Leuschen M.P., El Refaey H., Hamada F.M., Rojas P. The antioxidant properties of zinc and metallothionein. Neurochem. Int. 1996, 29:159-166.
12. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
13. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
14. Franceschi C., Olivieri F., Marchegiani F., Cardelli M., Cavallone L., Capri M., Salvioli S., Valensin S., De Benedictis G., Di Iorio A., Caruso C., Paolisso G., Monti D. Genes involved in immune response/inflammation IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech. Ageing Dev. 2005, 126:351-361.
15. Giacconi R., Cipriano C., Albanese F., Boccoli G., Saba V., Olivieri F., Franceschi C., Mocchegiani E. The -174 G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp. Gerontol. 2004, 39:621-628.
16. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., Gasparini N., Malavolta M., Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 2005, 6:407-413.
17. Giacconi R., Muti E., Malavolta M., Cipriano C., Costarelli L., Bernardini G., Gasparini N., Mariani E., Saba V., Boccoli G., Mocchegiani E. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol. Med. 2007, 13:388-395.
18. Giacconi R., Bonfigli A.R., Testa R., Sirolla C., Cipriano C., Marra M., Muti E., Malavolta M., Costarelli L., Piacenza F., Tesei S., Mocchegiani E. The +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol. Genet. Metab. 2008, 94:98-104.
19. Haddy N., Sass C., Maumus S., Marie B., Droesch S., Siest G., Lambert D., Visvikis S. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur. J. Hum. Genet. 2005, 13:109-117.
20. Hayashi Y., Hashizume T., Wakida K., Satoh M., Uchida Y., Watabe K., Matsuyama Z., Kimura A., Inuzuka T., Hozumi I. Association between metallothionein genes polymorphisms and sporadic amyotrophic lateral sclerosis in a Japanese population. Amyotroph. Lateral Scler. 2006, 7:22-26.
21. Hjelmborg B.J., Iachine I., Skytthe A., Vaupel J.W., McGue M., Koskenvuo M., Kaprio J., Pedersen N.L., Christensen K. Genetic influence on human lifespan and longevity. Hum. Genet. 2006, 119:312-321.
22. Hurme M., Paavilainen P.M., Pertovaara M., Jylhä M., Karhunen P.J., Hervonen A., Lehtimäki T. IgA levels are predictors of mortality in Finnish nonagenarians. Mech. Ageing Dev. 2005, 126:829-831.
23. Jerrard-Dunne P., Sitzer M., Risley P., Steckel D.A., Buehler A., von Kegler S., Markus H.S. Carotid Atherosclerosis Progression Study Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2003, 34:402-407.
24. Jylhä M., Paavilainen P., Lehtimäki T., Goebeler S., Karhunen P.J., Hervonen A., Hurme M. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J. Gerontol. A: Biol. Sci. Med. Sci. 2007, 62:1016-1021.
25. Kayaalti Z., Söylemezoĝlu T. The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population. Mol. Biol. Rep. 2010, 37:185-190.
26. Kayaalti Z., Mergen G., Söylemezoĝlu T. Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population. Toxicol. Appl. Pharmacol. 2010, 245:252-255.
27. Kita K., Miura N., Yoshida M., Yamazaki K., Ohkubo T., Imai Y., Naganuma A. Potential effect on cellular response to cadmium of a single-nucleotide A→G polymorphism in the promoter of the human gene for metallothionein IIA. Hum. Genet. 2006, 120:553-560.
28. Kwon C.S., Kountouri A.M., Mayer C., Gordon M.J., Kwun I.S., Beattie J.H. Mononuclear cell metallothionein mRNA levels in human subjects with poor zinc nutrition. Br. J. Nutr. 2007, 97:247-254.
29. Mazzatti D.J., Malavolta M., White A.J., Costarelli L., Giacconi R., Muti E., Cipriano C., Powell J.R., Mocchegiani E. Effects of interleukin-6 -174C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageing. Exp. Gerontol. 2008, 43:423-432.
30. Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 2000, 35:35-70.
31. Mocchegiani E., Malavolta M. Zinc-gene interaction related to inflammatory/immune response in ageing. Genes Nutr. 2008, 3:61-75.
32. Mocchegiani E., Giacconi R., Muti E., Rogo C., Bracci M., Muzzioli M., Cipriano C., Malavolta M. Zinc, immune plasticity, aging, and successful aging: role of metallothionein. Ann. N. Y. Acad. Sci. 2004, 1019:127-134.
33. Mocchegiani E., Giacconi R., Cipriano C., Malavolta M. NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J. Clin. Immunol. 2009, 29:416-425.
34. Neal B. Quantifying the importance of interleukin-6 for coronary heart disease. PLoS Med. 2008, 8:e84.
35. Perls T., Terry D. Understanding the determinants of exceptional longevity. Ann. Intern. Med. 2003, 139:445-449.
36. Pes G.M., Lio D., Carru C., Deiana L., Baggio G., Franceschi C., Ferrucci L., Oliveri F., Scola L., Crivello A., Candore G., Colonna-Romano G., Caruso C. Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin. Exp. Res. 2004, 16:244-248.
37. Reiner A.P., Diehr P., Browner W.S., Humphries S.E., Jenny N.S., Cushman M., Tracy R.P., Walston J., Lumley T., Newman A.B., Kuller L.H., Psaty B.M. Common promoter polymorphisms of inflammation and thrombosis genes and longevity in older adults: the cardiovascular health study. Atherosclerosis 2005, 181:175-183.
38. Salvioli S., Olivieri F., Marchegiani F., Cardelli M., Santoro A., Bellavista E., Mishto M., Invidia L., Capri M., Valensin S., Sevini F., Cevenini E., Celani L., Lescai F., Gonos E., Caruso C., Paolisso G., De Benedictis G., Monti D., Franceschi C. Genes, ageing and longevity in humans: problems, advantages and perspectives. Free Radic. Res. 2006, 40:1303-1323.
39. Samson S.L., Gedamu L. Molecular analyses of metallothionein gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 1998, 59:257-288.
40. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., Telera A., Lucchini G., Passeri G., Monti D., Franceschi C., Passeri M. The immune system in extreme longevity. Exp. Gerontol. 2008, 43:61-65.
41. Sciavolino P.J., Vilcek J. Regulation of metallothionein gene expression by TNF-alpha and IFN-beta in human fibroblasts. Cytokine 1995, 7:242-250.
42. Van-Bodegom D., May L., Meij H.J., Westendorp R.G. Regulation of human life histories: the role of the inflammatory host response. Ann. N. Y. Acad. Sci. 2007, 1100:84-97.